A Message From the CEO 

CEO Andy Theurer and Research and Development scientist Diane Wilcock

I had the opportunity during Medical Laboratory Professionals Week in April 2025 to learn from ARUP scientists who shared their advancements during our Research Expo. They included Diane Wilcock, MS, a scientist II in Research and Development, Histopathology, who is pictured here describing details of a breast cancer research project she participated in with ARUP medical directors. Their research is another example of ARUP’s commitment to work continually to improve the diagnostic accuracy of our tests.

At ARUP Laboratories, we continually evaluate new tools as we work to offer tests that help improve patient outcomes. We are committed to using new technology to enhance diagnostic accuracy while also streamlining workflows and reducing turnaround times.

I’m proud to share that, thanks to the expertise of our medical directors and the talented laboratory scientists with whom they work, ARUP this spring became the world’s first clinical lab to apply artificial intelligence (AI) screening to the entire ova and parasite testing process, as just one example.

ARUP was first in 2019 to use an AI-augmented tool to review trichrome-stained slides to screen for gastrointestinal parasites. As of March of this year, we’re also now using AI to examine wet-mount slides, making ARUP the world’s first lab to use AI for both parts of the ova and parasite testing process.

You can read more about this advancement and why it revolutionizes testing for parasites in this edition of Magnify.

In these pages, you will also find spotlights on testing that provides early clues that may lead to cancer diagnoses. Gillian Jones poignantly demonstrates the value of one noninvasive screening test by sharing the story of her colorectal cancer diagnosis. Raising awareness about potentially lifesaving tests is a motivator behind each new edition of Magnify.

Enjoy these stories and others, and don’t forget to subscribe to Magnify to make sure you’re alerted when a new edition drops.

Andy Theurer 
CEO